Wang, Guochun
Bi, Liqi
Li, Xiangpei
Li, Zhijun
Zhao, Dongbao
Chen, Jinwei
He, Dongyi
Wang, Chia-Ning
Wu, Tao
Dueñas, Héctor
Skljarevski, Vladimir
Yue, Li
Article History
Received: 10 September 2018
Accepted: 24 March 2019
First Online: 22 April 2019
Ethics approval and consent to participate
: The study protocol was approved by ethics review boards (ERB) covering each site, including: ERB of China-Japan Friendship Hospital; Ethics Committee of Guanghua Hospital; ERB of the Third Xiangya Hospital of Central South University; ERB of Anhui Provincial Hospital; Shanghai Changhai Hospital Ethics Committee; ERB of Jilin University China-Japan Union Hospital; Clinical Medical Ethics Committee of the First Affiliated Hospital of Bengbu Medical College; ERB of the Second Xiangya Hospital of Central South University; ERB of the First Affiliated Hospital of Anhui Medical University; ERB of Tianjin Medical University General Hospital; ERB of West China Hospital of Sichuan University; ERB of the General Hospital of Shenyang Military Region; ERB of the First Affiliated Hospital of Jinan University; ERB of Nanfang Hospital; ERB of Pingxiang People’s Hospital; and ERB of Zhuzhou Central Hospital.Written informed consent was obtained from all patients before participation in the study.
: Not applicable.
: GW, LB, XL, ZL, DZ, JC, and DH have no conflicts of interest to report. HD, LY, CW, TW, and VS are or were employees and minor shareholders of Eli Lilly and Company.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.